Literature DB >> 2161552

Stereospecific blockade of N-methyl-D-aspartate transmission by MK 801 prevents priming of SKF 38393-induced turning.

M Morelli1, G Di Chiara.   

Abstract

In rats unilaterally lesioned with 6-hydroxydopamine, the D-1 agonist SKF 38393 (3 mg/kg SC) induced contralateral turning only after priming with a dopaminergic agonist such as apomorphine. Administration of the N-methyl-D-aspartate receptor antagonist (+) MK 801 (0.1 mg/kg IP) 15 min before apomorphine (0.1 mg/kg SC) prevented the ability of apomorphine to act as a primer while potentiating its acute contralateral turning effects. The inactive isomer (-) MK 801 was without effect. The results indicate that the N-methyl-D-aspartate receptor exerts a permissive role on priming.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2161552     DOI: 10.1007/BF02244143

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  4 in total

1.  [3H]MK-801 labels a site on the N-methyl-D-aspartate receptor channel complex in rat brain membranes.

Authors:  E H Wong; A R Knight; G N Woodruff
Journal:  J Neurochem       Date:  1988-01       Impact factor: 5.372

2.  Agonist-induced homologous and heterologous sensitization to D-1- and D-2-dependent contraversive turning.

Authors:  M Morelli; G Di Chiara
Journal:  Eur J Pharmacol       Date:  1987-09-02       Impact factor: 4.432

3.  Time and dose dependence of the 'priming' of the expression of dopamine receptor supersensitivity.

Authors:  M Morelli; S Fenu; L Garau; G Di Chiara
Journal:  Eur J Pharmacol       Date:  1989-03-21       Impact factor: 4.432

4.  Selective impairment of learning and blockade of long-term potentiation by an N-methyl-D-aspartate receptor antagonist, AP5.

Authors:  R G Morris; E Anderson; G S Lynch; M Baudry
Journal:  Nature       Date:  1986 Feb 27-Mar 5       Impact factor: 49.962

  4 in total
  6 in total

1.  MK801 attenuates behavioural adaptation to chronic nicotine administration in rats.

Authors:  M Shoaib; I P Stolerman
Journal:  Br J Pharmacol       Date:  1992-03       Impact factor: 8.739

2.  Blockade ofNMDA receptors differentially affectsD-1 andD-2 mediated turning behavior in the 6-hydroxydopamine model of Parkinson.

Authors:  M Morelli; S Fenu; A Pinna; A Cozzolino; G Di Chiara
Journal:  Amino Acids       Date:  1991-06       Impact factor: 3.520

3.  Development of both conditioning and sensitization of the behavioral activating effects of amphetamine is blocked by the non-competitive NMDA receptor antagonist, MK-801.

Authors:  J Stewart; J P Druhan
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

4.  Effects of MK-801 stereoisomers on schedule-controlled behavior in rats.

Authors:  R F Genovese; X C Lu
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

Review 5.  The 6-hydroxydopamine model of Parkinson's disease.

Authors:  Nicola Simola; Micaela Morelli; Anna R Carta
Journal:  Neurotox Res       Date:  2007-04       Impact factor: 3.911

6.  Involvement of Glutamate NMDA Receptors in the Acute, Long-Term, and Conditioned Effects of Amphetamine on Rat 50 kHz Ultrasonic Vocalizations.

Authors:  Giulia Costa; Micaela Morelli; Nicola Simola
Journal:  Int J Neuropsychopharmacol       Date:  2015-05-19       Impact factor: 5.176

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.